A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MAE / major adverse events

[Related PubMed/MEDLINE]
Total Number of Papers: 132
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MAE  (>> Co-occurring Abbreviation)
Long Form:   major adverse events
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A Frailty-Based Risk Score Predicts Morbidity and Mortality After Elective Endovascular Repair of Descending Thoracic Aortic Aneurysms. DTAA, TEVAR
2020 ascular disease in patients with atrial fibrillation. A report from Polish participants in the EORP-AF General Long-Term Registry. AF, NOAC, PAD, VD, VKA
2020 Effect and safety of 4% albumin in the treatment of cardiac surgery patients: study protocol for the randomized, double-blind, clinical ALBICS (ALBumin In Cardiac Surgery) trial. ALBICS, CPB, HES, MACE
2020 Effect of Concomitant Coronary Artery Bypass Grafting on Outcomes of Ascending Aortic Replacement. AAR, AAR, CI, MI, OM, OR
2020 Five-year results of the INSPIRATION study for the INCRAFT low-profile endovascular aortic stent graft system. ---
2020 Jetstream Atherectomy System for Treatment of Femoropopliteal Artery Disease: A Single Center Experience and Mid-term Outcomes. DEB, FPAD
2020 One-year results from the DETOUR I trial of the PQ Bypass DETOUR System for percutaneous femoropopliteal bypass. CD-TVR
2020 P2Y12 inhibitor loading dose before catheterization in ST-segment elevation myocardial infarction: Is this the best strategy? Hb, LD, LD-PRE, PCI, STEMI
2020 Percutaneous mechanical atherothrombectomy using the RotarexS device in peripheral artery in-stent restenosis or occlusion: a French retrospective multicenter study on 128 patients. ISR, MI, PMD, TLR
10  2020 Perioperative and Long-Term Outcomes After Thoracoabdominal Aortic Aneurysm Repair of Chronic Dissection Etiology. AOR, CD, DA, SCI, TAAA
11  2020 Prognostic value of admission electrocardiographic findings in non-ST-segment elevation myocardial infarction. ACS QUIK, ECG, NSTEMI, STD, TSTE, TWI
12  2020 Sex-Related Differences in the Outcomes of Endovascular Interventions for Chronic Limb-Threatening Ischemia: Results from the LIBERTY 360 Study. CLTI, TVR
13  2020 Single-Center Vascular Hub Experience after 7weeks of COVID-19 Pandemic in Lombardy (Italy). ---
14  2020 Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia. CLTI, OA, PAD, RC, TVR
15  2020 Yes, we should abandon pre-treatment positional testing of the cervical spine. CS, VBI
16  2019 30-day adverse events, length of stay and re-admissions following surgical management of pelvic/acetabular fractures. CHF, LOS, ORIF, SAE, UTI
17  2019 Balloon-Expandable Vascular Covered Stent in the Treatment of Iliac Artery Occlusive Disease: 9-Month Results from the BOLSTER Multicenter Study. CI, MI, TLR, WIQ
18  2019 Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes. MACE, MI, SCAD
19  2019 Cardiac Troponin Elevation in PatientsWithout a Specific Diagnosis. cTn
20  2019 Comparison of major adverse event rates after elective endovascular aneurysm repair in New England using a novel measure of complication severity. CI, EVAR, OR
21  2019 Does metabolic syndrome influence short and long term durability of carotid endarterectomy and stenting? CEA, MetS
22  2019 Impact of left ventricular ejection fraction on the outcomes of open repair of descending thoracic and thoracoabdominal aneurysms. CI, DTA, LVEF, OR, TAAA
23  2019 Long-Term Effects of Bosentan on Cardiovascular Events in Hispanic Patients with Intermittent Claudication: Four-Year Follow-up of the CLAU Trial : The CLAU Randomized Trial Long-Term Outcome. CLAU, HR, MACE, MALE, MI, PAD, TLR
24  2019 Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries. HR, MI, MI-CAD
25  2019 One-Year Results of the LIBERTY 360 Study: Evaluation of Acute and Midterm Clinical Outcomes of Peripheral Endovascular Device Interventions. CLI, PAD, QOL, RC
26  2019 Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study. CD-TLR, CI, CLI, DCB, IC
27  2019 Percutaneous left atrial appendage occlusion with the Amulet device: The impact of device disc position upon periprocedural and long-term outcomes. LAA
28  2019 Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: Results of Disrupt PAD II. DUS, IVL
29  2019 Risk Factors for Major Adverse Events after Surgical Closure of Ventricular Septal Defect in Patients Less than 1 Year of Age: A Single-Center Retrospective. ICU, MV, VSD
30  2019 Risk factors for post-discharge complications and readmissions in home-discharges after elective posterior lumbar fusions. AAE, PLFs, SAE
31  2019 The Randomized Freeway Stent Study: Drug-Eluting Balloons Outperform Standard Balloon Angioplasty for Postdilatation of Nitinol Stents in the SFA and PI Segment. ABI, DEB, PTA, TLR
32  2018 Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis. CI, HR, ISR, PCI, UA
33  2018 Jetstream Atherectomy System treatment of femoropopliteal arteries: Results of the post-market JET Registry. TLR/TVR
34  2018 Long-term outcomes of patients with diabetes mellitus undergoing percutaneous intervention for popliteal and infrapopliteal peripheral arterial disease. DM, PAD, PVI
35  2018 Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery Disease. CD-TLR, CD-TVR, MI
36  2018 Novel Nitinol Stent for Lesions up to 24 cm in the Superficial Femoral and Proximal Popliteal Arteries: 24-Month Results From the TIGRIS Randomized Trial. SFA/PPA, TLR
37  2018 Perioperative Outcomes From the Prospective Multicenter Least Invasive Fast-Track EVAR (LIFE) Registry. EVAR, ICU, LIFE
38  2018 Transradial versus tibiopedal access approach for endovascular intervention of superficial femoral artery chronic total occlusion. CTO, SFA, TPA
39  2017 AVJ-514 Trial - Baseline Characteristics and 30-Day Outcomes Following MitraClip Treatment in a Japanese Cohort. APS, EF, LV, MR, STS
40  2017 Clinical Impact of Intravascular Ultrasound Guidance During Endovascular Treatment of Subclavian Artery Disease. CI, EVT, HR, IVUS, MACE, MI
41  2017 Endovascular Therapy for Infrainguinal Artery Disease With Coronary Devices: A Retrospective Observational Study Comparing Drug-Eluting Stents Versus Bioresorbable Vascular Scaffolds. BVS, DES, TVR
42  2017 Postmarket Clinical Experience with the INCRAFT AAA Stent Graft System for Challenging Access Routes. ---
43  2017 Prediction of adverse events after catheter-based procedures in adolescents and adults with congenital heart disease in the IMPACT registry. CHD, IMPACT
44  2017 Prognostic value of lower limb perfusion single-photon emission computed tomography-computed tomography in patients with lower limb atherosclerotic peripheral artery disease. LMBR, PAD, SPECT/CT
45  2017 Relationship between hospital procedure volume and complications following congenital cardiac catheterization: A report from the IMproving Pediatric and Adult Congenital Treatment (IMPACT) registry. CHD, IMPACT
46  2017 Results From the VISIBILITY Iliac Study: Primary and Cohort Outcomes at 9 Months. ABI, CD-TLR, CD-TVR, EIA
47  2017 Results of AFX Unibody Stent-Graft Implantation in Patients With TASC D Aortoiliac Lesions and Coexistent Abdominal Aortic Aneurysms. AAA, ABI, AIOD, CIA, EIA, TASC
48  2017 Safety and effectiveness of the Phoenix Atherectomy System in lower extremity arteries: Early and midterm outcomes from the prospective multicenter EASE study. ---
49  2017 The prognostic value of asymmetric dimethylarginine in patients with cardiac syndrome X. ADMA
50  2016 Benefits of robotic cystectomy with intracorporeal diversion for patients with low cardiorespiratory fitness: A prospective cohort study. AT, CPET, iRARC, LOS
51  2016 Carotid artery stenting for vulnerable plaques on MR angiography and ultrasonography: utility of dual protection and blood aspiration method. CAS, DWI, ICA, TOF-MRA, US
52  2016 Clinical Profi le and Predictors of Outcomes of Patients with Peripartum Cardiomyopathy: The Philippine Heart Center Experience. EF
53  2016 Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. ACP, CKD, LAAO, TIA
54  2016 One-Year Outcomes of Endovascular Aneurysm Repair in High-Risk Patients Using the Endurant Stent-Graft: Comparison of the ASA Classification and SVS/AAVS Medical Comorbidity Grading System for the Prediction of Mortality and Adverse Events. ASA, EVAR
55  2016 Procedural Success and Adverse Events in Pulmonary Artery Stenting: Insights From the NCDR. PA
56  2016 The CLEAR-ROAD study: evaluation of a new dual layer micromesh stent system for the carotid artery. EPDs, MI
57  2016 The Effect of Haemodialysis Access Types on Cardiac Performance and Morbidities in Patients with Symptomatic Heart Disease. AVA, CVC, ESRD
58  2016 The MitraClip Asia-Pacific registry: Differences in outcomes between functional and degenerative mitral regurgitation. DMR, fMR, MARS, MR
59  2016 Twelve-Month Results of the Nitinol Astron Stent in Iliac Artery Lesions. ABI, TLR, WIQ
60  2015 Carotid stenting with distal protection in high-surgical-risk patients: one-year results of the ASTI trial. MI
61  2015 Management of Patients with Internal Carotid Artery Near-total Occlusion: An Updated Meta-analysis. BMT, CAS, CEA, ICA, IRs, MI, PYs, TIA
62  2015 Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury. AKI, CM, NGAL, SCr, sNGAL
63  2015 Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: a sub-study of the PROTECT II trial. 3VD, IABP
64  2015 Physician-initiated prospective Italian Registry of carotid stenting with the C-Guard mesh-stent: the IRON-Guard registry. Rationale and design. CAS, EPD, MAEs
65  2015 Prognostic value of (18)F-fluorodeoxyglucose PET-CT imaging in acute aortic syndromes: comparison with serological biomarkers of inflammation. AAS, CRP, DD, FDG, PET-CT
66  2015 The prognostic value of the serum eicosapentaenoic acid to arachidonic acid ratio in relation to clinical outcomes after endovascular therapy in patients with peripheral artery disease caused by femoropopliteal artery lesions. AA, CI, EPA, EVT, HR, MALE, PAD
67  2015 Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study. DCB, LLL
68  2015 Usefulness of dual protection combined with blood aspiration for distal embolic protection during carotid artery stenting. CAS, DWI, ICA
69  2014 Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. ABI, DEB, LLL, TLR
70  2014 Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study. AF, CI, COPD, HR
71  2014 Contemporary management of critical lower limb ischemia in TASC D lesions with subintimal angioplasty in femoro-popliteal lesions, tibial angioplasty and sequential compression biomechanical device for infra-inguinal arterial occlusion. Experience and quality of life outcome learned over 25 years. AFS, CELA, CLI, DUAM, PVD, QALY, SCBD, SIA, TBA
72  2014 Factors that determine the length of stay after carotid endarterectomy represent opportunities to avoid financial losses. CEA, LOS
73  2014 Impact of elevated perioperative fasting blood glucose on carotid artery stenting outcomes. CAS, DM, FBS, IFG
74  2014 Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). IABP, PCI
75  2014 Improvement in aortic valve area using a new "hour glass" shaped valvuloplasty balloon compared with standard cylindrical balloons in severe aortic stenosis patients. AI, AVA, AVCD, BAV, LVEF, STS
76  2014 Large false lumen area is a predictor of failed false lumen volume reduction after stent-graft repair in type B aortic dissection. CT, FL, TEVAR
77  2014 Percutaneous mitral valve repair with the MitraClip: early results from the MitraClip Asia-Pacific Registry (MARS). MARS, MR
78  2014 Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: twelve-month results from the PATENT study. ELA, ISR, TLR
79  2014 Potential cause of delayed strokes following carotid artery stenting. CAS, CEA, IVUS
80  2014 Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. PPCM
81  2013 A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. HM, ICD
82  2013 Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. PPCM
83  2013 Early report from an investigator-initiated investigational device exemption clinical trial on physician-modified endovascular grafts. PMEG
84  2013 Final results of the Chronic Total Occlusion Crossing With the Ocelot System II (CONNECT II) study. CTOs, SFA
85  2013 Initial results of carotid artery stenting in Japan. CAS
86  2013 Preoperative anemia does not increase the risks of early surgical revascularization after myocardial infarction. MI
87  2013 Rate of repair in minimally invasive mitral valve surgery. ---
88  2013 Serum albumin and C-reactive protein levels predict clinical outcome in hemodialysis patients undergoing endovascular therapy for peripheral artery disease. CRP, EVT, MALE, PAD, TLR
89  2013 Sustained patency and clinical improvement following treatment of atherosclerotic iliac artery disease using the Assurant cobalt iliac balloon-expandable stent system. TLR/TVR
90  2013 Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry. ACP, LAA
91  2012 A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). ---
92  2012 Carotid artery stenting: a single center "real world" experience. CAD, CAS
93  2012 Contemporary outcomes for surgical mitral valve repair: a benchmark for evaluating emerging mitral valve technology. MV
94  2012 Differential effect of nutritional status on vascular surgery outcomes in a Veterans Affairs versus private hospital setting. OR, VA
95  2012 Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study. ABI, ISR, PTA
96  2012 Historical perspective of carotid artery stenting in Japan: analysis of 8,092 cases in The Japanese CAS survey. CAS
97  2012 Prospective, multicenter European study of the GORE flow reversal system for providing neuroprotection during carotid artery stenting. CAS, EPDs, MI
98  2012 The Ratio of Descending Aortic Enhancement to Main Pulmonary Artery Enhancement Measured on Pulmonary CT Angiography as a Finding to Predict Poor Outcome in Patients with Massive or Submassive Pulmonary Embolism. DAE, ICC, LVD, MPAE, PCTA, PE, RVD
99  2011 Is age of 80 years a threshold for carotid revascularization? CAS, CEA
100  2011 Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. CAS, OPC